Frataxin and Mitochondrial Carrier Proteins, Mrs3p and Mrs4p, Cooperate in Providing Iron for Heme Synthesis
Yan Zhang,Elise R. Lyver,Simon A. B. Knight,Emmanuel Lesuisse,Andrew Dancis
DOI: https://doi.org/10.1074/jbc.m500397200
2005-01-01
Abstract:Frataxin is a conserved mitochondrial protein implicated in cellular iron metabolism. Deletion of the yeast frataxin homolog (YFH1) was combined with deletions of MRS3 and MRS4, mitochondrial carrier proteins implicated in iron homeostasis. As previously reported, the Δyfh1 mutant accumulated iron in mitochondria, whereas the triple mutant (ΔΔΔ) did not. When wild-type, Δmrs3/4, Δyfh1, and ΔΔΔ strains were incubated anaerobically, all strains were devoid of heme and protected from iron and oxygen toxicity. The cultures were then shifted to air for a short time (4–5 h) or a longer time (15 h), and the evolving mutant phenotypes were analyzed (heme-dependent growth, total heme, cytochromes, heme proteins, and iron levels). A picture emerges from these data of defective heme formation in the mutants, with a markedly more severe defect in the ΔΔΔ than in the individual Δmrs3/4 or Δyfh1 mutants (a "synthetic" defect in the genetic sense). The defect(s) in heme formation could be traced to lack of iron. Using a real time assay of heme biosynthesis, porphyrin precursor and iron were presented to permeabilized cells, and the appearance and disappearance of fluorescent porphyrins were followed. The Mrs3/4p carriers were required for rapid iron transport into mitochondria for heme synthesis, whereas there was also evidence for an alternative slower system. A different role for Yfh1p was observed under conditions of low mitochondrial iron and aerobic growth (revealed in the ΔΔΔ), acting to protect bioavailable iron within mitochondria and to facilitate its use for heme synthesis. Frataxin is a conserved mitochondrial protein implicated in cellular iron metabolism. Deletion of the yeast frataxin homolog (YFH1) was combined with deletions of MRS3 and MRS4, mitochondrial carrier proteins implicated in iron homeostasis. As previously reported, the Δyfh1 mutant accumulated iron in mitochondria, whereas the triple mutant (ΔΔΔ) did not. When wild-type, Δmrs3/4, Δyfh1, and ΔΔΔ strains were incubated anaerobically, all strains were devoid of heme and protected from iron and oxygen toxicity. The cultures were then shifted to air for a short time (4–5 h) or a longer time (15 h), and the evolving mutant phenotypes were analyzed (heme-dependent growth, total heme, cytochromes, heme proteins, and iron levels). A picture emerges from these data of defective heme formation in the mutants, with a markedly more severe defect in the ΔΔΔ than in the individual Δmrs3/4 or Δyfh1 mutants (a "synthetic" defect in the genetic sense). The defect(s) in heme formation could be traced to lack of iron. Using a real time assay of heme biosynthesis, porphyrin precursor and iron were presented to permeabilized cells, and the appearance and disappearance of fluorescent porphyrins were followed. The Mrs3/4p carriers were required for rapid iron transport into mitochondria for heme synthesis, whereas there was also evidence for an alternative slower system. A different role for Yfh1p was observed under conditions of low mitochondrial iron and aerobic growth (revealed in the ΔΔΔ), acting to protect bioavailable iron within mitochondria and to facilitate its use for heme synthesis. Frataxin is a mitochondrial protein, the deficiency of which has been implicated in the human disease Friedreich's ataxia (1Campuzano V. Montermini L. Molto M.D. Pianese L. Cossee M. Cavalcanti F. Monros E. Rodius F. Duclos F. Monticelli A. Science. 1996; 271: 1423-1427Crossref PubMed Scopus (2323) Google Scholar). This is a progressive disease in which specialized tissues (neurons of dorsal root ganglia, cardiac muscle cells, and pancreatic beta cells) undergo mitochondrial degeneration and cell death (2Puccio H. Simon D. Cossee M. Criqui-Filipe P. Tiziano F. Melki J. Hindelang C. Matyas R. Rustin P. Koenig M. Nat. Genet. 2001; 27: 181-186Crossref PubMed Scopus (605) Google Scholar). A link to iron metabolism has been established, originally by the characterization of a yeast strain deleted for the yeast frataxin homolog (YFH1) (3Babcock M. de Silva D. Oaks R. Davis-Kaplan S. Jiralerspong S. Montermini L. Pandolfo M. Kaplan J. Science. 1997; 276: 1709-1712Crossref PubMed Scopus (831) Google Scholar). In this yeast mutant, iron accumulates in mitochondria as toxic inorganic precipitates (4Lesuisse E. Santos R. Matzanke B.F. Knight S.A. Camadro J.M. Dancis A. Hum. Mol. Genet. 2003; 12: 879-889Crossref PubMed Scopus (219) Google Scholar); at the same time, iron proteins, including iron-sulfur and heme proteins, are decreased or inactive (4Lesuisse E. Santos R. Matzanke B.F. Knight S.A. Camadro J.M. Dancis A. Hum. Mol. Genet. 2003; 12: 879-889Crossref PubMed Scopus (219) Google Scholar, 5Rotig A. Sidi D. Munnich A. Rustin P. Trends Mol. Med. 2002; 8: 221-224Abstract Full Text Full Text PDF PubMed Scopus (42) Google Scholar). The iron accumulations in mitochondria generate damaging oxidative intermediates. Many of the phenotypes of the frataxin deletion mutant appear to be secondary consequences of oxidative damage to proteins, lipids, and DNA (6Wilson R. Roof D. Nat. Genet. 1997; 16: 352-357Crossref PubMed Scopus (326) Google Scholar, 7Karthikeyan G. Santos J.H. Graziewicz M.A. Copeland W.C. Isaya G. Van Houten B. Resnick M.A. Hum. Mol. Genet. 2003; 12: 3331-3342Crossref PubMed Scopus (84) Google Scholar). Critical to understanding the functions of frataxin will be the ability to distinguish primary consequences of lack of frataxin from secondary toxic events. Frataxin has a highly conserved sequence and structure. Human (8Dhe-Paganon S. Shigeta R. Chi Y.I. Ristow M. Shoelson S.E. J. Biol. Chem. 2000; 275: 30753-30756Abstract Full Text Full Text PDF PubMed Google Scholar), bacterial (9Cho S.J. Lee M.G. Yang J.K. Lee J.Y. Song H.K. Suh S.W. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 8932-8937Crossref PubMed Scopus (104) Google Scholar), and yeast (10He Y.A. Proteasa S.V. Zhang Y. Lesuisse E. Dancis A. Stemmler T.L. Biochemistry. 2004; 51: 16254-16262Crossref Scopus (140) Google Scholar) forms have been structurally characterized and exhibit similar folds. The structures are characterized by a platform of six or seven β-sheets and two α-helices in a separate plane, with a hydrophobic core and a negatively charged groove between the α-helices. The biochemical functions of frataxin have remained poorly defined, in part because of difficulties in distinguishing primary and secondary phenotypes of frataxin-deficient mutants. Iron-sulfur cluster formation (11Muhlenhoff U. Richhardt N. Ristow M. Kispal G. Lill R. Hum. Mol. Genet. 2002; 15: 2025-2036Crossref Scopus (287) Google Scholar), aconitase repair (12Bulteau A.L. O'Neill H.A. Kennedy M.C. Ikeda-Saito M. Isaya G. Szweda L.I. Science. 2004; 305: 242-245Crossref PubMed Scopus (319) Google Scholar), heme synthesis (4Lesuisse E. Santos R. Matzanke B.F. Knight S.A. Camadro J.M. Dancis A. Hum. Mol. Genet. 2003; 12: 879-889Crossref PubMed Scopus (219) Google Scholar), antioxidant function (5Rotig A. Sidi D. Munnich A. Rustin P. Trends Mol. Med. 2002; 8: 221-224Abstract Full Text Full Text PDF PubMed Scopus (42) Google Scholar, 13Santos R. Buisson N. Knight S.A. Dancis A. Camadro J.M. Lesuisse E. Mol. Microbiol. 2004; 54: 507-519Crossref PubMed Scopus (42) Google Scholar), and iron storage (14Gakh O. Adamec J. Gacy A.M. Twesten R.D. Owen W.G. Isaya G. Biochemistry. 2002; 41: 6798-6804Crossref PubMed Scopus (114) Google Scholar) have been proposed as functions of frataxin. Protein interactions within mitochondria are likely to play an important role in frataxin functions, and interactions with Isu1p (15Gerber J. Muhlenhoff U. Lill R. EMBO Rep. 2003; 4: 906-911Crossref PubMed Scopus (314) Google Scholar), aconitase (12Bulteau A.L. O'Neill H.A. Kennedy M.C. Ikeda-Saito M. Isaya G. Szweda L.I. Science. 2004; 305: 242-245Crossref PubMed Scopus (319) Google Scholar), and ferrochelatase (4Lesuisse E. Santos R. Matzanke B.F. Knight S.A. Camadro J.M. Dancis A. Hum. Mol. Genet. 2003; 12: 879-889Crossref PubMed Scopus (219) Google Scholar, 16Yoon T. Cowan J.A. J. Biol. Chem. 2004; 279: 25943-25946Abstract Full Text Full Text PDF PubMed Scopus (250) Google Scholar) have been described. Isu1p is a scaffold protein that functions as an intermediate in Fe-S cluster synthesis (17Garland S.A. Hoff K. Vickery L.E. Culotta V.C. J. Mol. Biol. 1999; 294: 897-907Crossref PubMed Scopus (167) Google Scholar, 18Agar J.N. Krebs C. Frazzon J. Huynh B.H. Dean D.R. Johnson M.K. Biochemistry. 2000; 39: 7856-7862Crossref PubMed Scopus (386) Google Scholar), and a role of frataxin in this process has been supported by biochemical studies (11Muhlenhoff U. Richhardt N. Ristow M. Kispal G. Lill R. Hum. Mol. Genet. 2002; 15: 2025-2036Crossref Scopus (287) Google Scholar, 19Chen O.S. Hemenway S. Kaplan J. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 12321-12326Crossref PubMed Scopus (138) Google Scholar, 20Yoon T. Cowan J.A. J. Am. Chem. Soc. 2003; 125: 6078-6084Crossref PubMed Scopus (330) Google Scholar). Genetic data also support this function of frataxin, in that mutations in various genes involved in Fe-S cluster synthesis combine with frataxin mutations to produce synthetic lethality (21Ramazzotti A. Vanmansart V. Foury F. FEBS Lett. 2004; 557: 215-220Crossref PubMed Scopus (112) Google Scholar, 22Aloria K. Schilke B. Andrew A. Craig E.A. EMBO Rep. 2004; 5: 1096-1101Crossref PubMed Scopus (95) Google Scholar). Ferrochelatase is the mitochondrial enzyme involved in iron insertion into porphyrin to make heme. Consistent with a role in heme synthesis, a high affinity interaction of frataxin and ferrochelatase has been described (4Lesuisse E. Santos R. Matzanke B.F. Knight S.A. Camadro J.M. Dancis A. Hum. Mol. Genet. 2003; 12: 879-889Crossref PubMed Scopus (219) Google Scholar, 10He Y.A. Proteasa S.V. Zhang Y. Lesuisse E. Dancis A. Stemmler T.L. Biochemistry. 2004; 51: 16254-16262Crossref Scopus (140) Google Scholar, 20Yoon T. Cowan J.A. J. Am. Chem. Soc. 2003; 125: 6078-6084Crossref PubMed Scopus (330) Google Scholar). Mrs3p and Mrs4p are homologous proteins located in the mitochondrial inner membrane. These proteins belong to the mitochondrial carrier family and have been implicated in iron metabolism (23Foury F. Roganti T. J. Biol. Chem. 2002; 277: 24475-24483Abstract Full Text Full Text PDF PubMed Scopus (145) Google Scholar). Some data suggest that these carriers are able to transport iron into mitochondria (24Muhlenhoff U. Stadler J.A. Richhardt N. Seubert A. Eickhorst T. Schweyen R.J. Lill R. Wiesenberger G. J. Biol. Chem. 2003; 278: 40612-40620Abstract Full Text Full Text PDF PubMed Scopus (169) Google Scholar), although the mutant phenotypes resulting from deletions of both genes (Δmrs3/4) are mild. Complex regulatory changes occurring in the Δmrs3/4 mutant strains make it difficult to ascertain which effects are primary and which are secondary (25Li L. Kaplan J. J. Biol. Chem. 2004; 279: 33653-33661Abstract Full Text Full Text PDF PubMed Scopus (97) Google Scholar). Knockouts of the major mitochondrial carriers involved in delivery of iron for heme synthesis would be expected to cause heme deficiency, yet this has not been observed in the Δmrs3/4 mutant. Cytochrome levels are often good indicators of heme synthesis, and these are low or abnormal in mutants involved in heme biosynthesis (26Labbe-Bois R. Camadro J.M. Winkelmann G. Winge D.R. Metal Ions in Fungi. Marcel Dekker, Inc., New York1994: 413-454Google Scholar). Cytochromes in the Δmrs3/4 mutant were reportedly normal (23Foury F. Roganti T. J. Biol. Chem. 2002; 277: 24475-24483Abstract Full Text Full Text PDF PubMed Scopus (145) Google Scholar). Here we describe a novel genetic and biochemical interaction implicating frataxin and Mrs3/4p in heme synthesis. In some cases, the various yeast strains were grown in the absence of oxygen and shifted to air, thereby providing a uniform starting point for experiments without heme and without iron toxicity. The roles of the Mrs3/4p carriers and frataxin in iron handling for heme synthesis could then be distinguished by biochemical assays. By using these types of experiments, the Mrs3/4p carriers were implicated in iron delivery into mitochondria, whereas Yfh1p was implicated in making iron bioavailable within mitochondria. Strains and Genotypes—53–76 (MATα ura3–52 lys2–801(amber) ade2–101(ochre) trp1-Δ63 his3-Δ200 leu2-Δ1 cyh2) was derived from strain YPH500 by growth in the presence of cycloheximide and selection for resistant clones. Similarly, 53–75, referred to here as "wild type" (MATa ura3–52 lys2–801(amber) ade2–101(ochre) trp1-Δ63 his3-Δ200 leu2-Δ1 cyh2), was derived from YPH499 by a similar procedure. 85–74, referred to here as Δmrs3/4 (MATa ura3–52 lys2–801(amber) ade2–101(ochre) trp1-Δ63 his3-Δ200 leu2-Δ1 cyh2 Δmrs4::KAN Δmrs3::URA3), was made by introducing deletions for MRS4 (using a G418 cassette) and MRS3 (using URA3) into strain 53–75 (27Petracek M.E. Longtine M.S. Methods Enzymol. 2002; 350: 445-469Crossref PubMed Scopus (66) Google Scholar). Correctness of the genomic insertions was verified by PCR. 59–32, called the Δyfh1 shuffle strain (MATa ura3–52 lys2–801(amber) ade2–101(ochre) trp1-Δ63 his3-Δ200 leu2-Δ1 cyh2 Δyfh1::TRP1 [pRS318-LEU2-CYH2-YFH1]) was constructed from 53–75 as described. In this strain, the Δyfh1 mutation is covered by the CEN and CYH2-containing plasmid pRS318 with the YFH1 HindIII genomic fragment (28Gordon D.M. Kogan M. Knight S.A. Dancis A. Pain D. Hum. Mol. Genet. 2001; 10: 259-269Crossref PubMed Scopus (32) Google Scholar). The plasmid was removed by counterselection on medium containing 10 μg/ml cycloheximide, which is toxic in the presence of the CYH2 allele. The mutant following removal of the covering plasmid was called simply Δyfh1. 82–43 (MATa ura3–52 lys2–801(amber) ade2–101(ochre) his3-Δ200 cyh2 Δyfh1::TRP1 Δmrs4::KAN Δmrs3::URA3 [pRS318-YFH1-LEU2]) was a shuffle strain derived from 59–32 in which deletions for MRS4 (using a G418 cassette) and MRS3 (using URA3) have been introduced. The pRS318 plasmid was removed by treatment with cycloheximide, and the mutant was referred to as ΔΔΔ or Δmrs3/4/Δyfh1. Genetic Procedures—Crosses were performed by patching strains of opposite mating types and picking zygotes with a micromanipulator after 4 h. Crossing of the shuffle strains with the 53–76 parental strain was performed in this manner, and the YFH1 plasmid was removed from the diploid by counterselection on cycloheximide before sporulation. Experiments with Δyfh1 or ΔΔΔ mutants were initiated with the shuffle strains, and the covering plasmid was removed by counterselection. Complete removal of the covering plasmid was verified for each experiment by testing for leucine auxotrophy, since the YFH1-bearing pRS318 plasmid also carried a LEU2 marker gene. For most experiments, counterselection was performed anaerobically by streaking shuffle strains on agar plates consisting of YPAD with 0.2% Tween 80, 40 μg/ml ergosterol, and 10 μg/ml cycloheximide in an anaerobic chamber. Media Composition—Rich YPAD medium contained 1% yeast extract, 2% peptone, 2% d-glucose, and 0.01% adenine. YPAR contained 2% raffinose instead of glucose. Defined medium contained 6.7 g/liter yeast nitrogen base without amino acids, 2% glucose, 0.8 g/liter amino acid supplements, and 1.5% Difco agar as a solidifying agent for agar plates. Iron-buffered plates consisted of modified defined medium to which pH buffer (50 mm MES, pH 6.1) and iron chelator (1 mm ferrozine) were added. Different amounts of ferrous iron (0, 20, 50, and 350 μm) were added back to establish windows of available free iron as described (29Stearman R. Yuan D.S. Yamaguchi-Iwai Y. Klausner R.D. Dancis A. Science. 1996; 271: 1552-1557Crossref PubMed Scopus (582) Google Scholar). For some experiments, the following additions were included: 0.2% Tween 80, 40 μg/ml ergosterol, 40 μg/ml methionine, and 20 or 50 μm hemin. Hemin stocks were made by dissolving powder in a small amount of 1 m KOH and diluting into a larger volume of buffer (0.2 m Tris-Cl, pH 8.0) and then adjusting the volume and pH to 7.8 with concentrated HCl to give a final concentration of 10 mm. For anaerobic growth, agar plates were placed in an anaerobic chamber with a BBL GasPak (BD Biosciences). For anaerobic growth of liquid cultures, argon gas (Airgas) was bubbled through the medium in sealed glass flasks. Cells were grown at 30 °C as stationary cultures (anaerobic) or with circular agitation (aerobic). Ferric Reductase—The assay was performed as described (30Lesuisse E. Knight S.A. Courel M. Santos R. Camadro J.-M. Dancis A. Genetics. 2005; 169: 107-122Crossref PubMed Scopus (43) Google Scholar). Iron Levels—Samples of permeabilized cells (800 μg of equivalent protein) or mitochondria (80 μg of equivalent protein) were placed in microcentrifuge tubes. Following treatment with iron-free nitric acid, these were subjected to metal analysis by inductively coupled plasma mass spectrometry (laboratory of Dr. Robert Poppenga, School of Veterinary Medicine, University of Pennsylvania, New Bolton Center, Kennett Square, PA). Catalase—Potassium phosphate buffer (1 ml, 30 mm, pH 7.0) was added to a quartz cuvette. H2O2 (10 μl, 1.3 m) was then added to give a 13 mm final concentration. The reaction was started by the addition of 10 μl of lysate from 30 × 106 cells, and absorbance at 240 nm was measured for 2 min. The rate of decrease, reflecting catalase activity, was converted to activity by the extinction coefficient 4.36 × 104 cm2/mol (31Roggenkamp R. Sahm H. Wagner F. FEBS Lett. 1974; 41: 283-286Crossref PubMed Scopus (124) Google Scholar). Aconitase—Activity was measured in permeabilized cells (10 μl) in assay buffer (50 mm Tris-Cl, pH 8.0, 20 mm isocitrate) with or without 0.6 m sorbitol. The assay follows conversion of isocitrate to cis-aconitate over time measured by absorbance at 240 nm (32Kennedy M.C. Emptage M.H. Dreyer J.L. Beinert H. J. Biol. Chem. 1983; 258: 11098-11105Abstract Full Text PDF PubMed Google Scholar). Ferrochelatase Activity in Mitochondrial Lysate (from Added Iron)— Protoporphyrin IX (PPIX 1The abbreviations used are: PPIX, protoporphyrin IX; PPO, protoporphyrinogen; MES, α-[N-morphilino]ethanesulfonic acid. ; 200 ng) was added to mitochondrial lysates (prepared in air) in 2 ml of assay buffer (0.1 m Tris-Cl, pH 7.5, 0.5% Tween 80). The lysate was rendered anaerobic by bubbling with argon for 5 min in a cuvette with a rubber septum. A base-line fluorescence tracing was obtained with excitation at 410 nm and emission at 632 nm. The assay was initiated by injection of 10 μm ferrous iron (final concentration) from a 200 μm stock of ferrous ammonium sulfate in an anaerobic stoppered vial. A time trace was collected, and the initial decrease in slope of the PPIX fluorescence represented the ferrochelatase activity in the lysate (33Camadro J.-M. Labbe-Bois R. J. Biol. Chem. 1988; 263: 11675-11682Abstract Full Text PDF PubMed Google Scholar, 34Shi Z. Ferreira G.C. Anal. Biochem. 2003; 318: 18-24Crossref PubMed Scopus (11) Google Scholar). Cell Permeabilization—Cells were grown anaerobically in sealed flasks containing YPAD supplemented with 0.2% Tween 80 and 20 μg/ml ergosterol bubbled with argon. After 48 h, the cultures were washed in water and resuspended in an equal volume of YPAR at an A600 of about 1. Cultures were grown in air for an additional 4 h at 30 °C with shaking and then harvested. After washing with water, cells were treated with 0.1 m Tris, pH 9.4, SO42−, 100 mm dithiothreitol for 10 min at 30 °C. Spheroplasts were formed by digestion with zymolyase (1 mg/g, wet weight; Seikagaku) in 10 ml of spheroplasting buffer (1.2 m sorbitol, 20 mm KH2PO4, pH 7.5) for 1 h at 30 °C. Spheroplasts were pelleted by centrifugation (1,500 × g), washed with buffer at room temperature, and allowed to metabolically recover in 20 ml of recovery solution (0.35 volumes of 2 m sorbitol per 0.75 volumes of YPAD medium) by incubating at 30 °C with gentle shaking for 20 min. Recovered spheroplasts were then pelleted by centrifugation (1,500 × g) at room temperature and gently resuspended in permeabilization buffer (20 mm Hepes KOH, pH 6.8, 400 mm sorbitol, 150 mm potassium acetate, 2 mm manganese acetate). The spheroplast suspensions were aliquoted into microcentrifuge tubes and suspended over liquid nitrogen vapors to allow slow freezing (35Achleitner G. Zweytick D. Trotter P.J. Voelker D.R. Daum G. J. Biol. Chem. 1995; 270: 29836-29842Abstract Full Text Full Text PDF PubMed Scopus (67) Google Scholar, 36Farrelly E. Amaral M.C. Marshall L. Huang S.G. Anal. Biochem. 2001; 293: 269-276Crossref PubMed Scopus (28) Google Scholar). Heme Synthesis in Permeabilized Cells (from Endogenous Iron)—An aliquot of permeabilized cells (100 μl of 0.5 g/ml, wet weight) was thawed and very gently added to assay buffer consisting of 50 mm Tris-Cl, pH 7.5, 0.6 m sorbitol in a water-jacketed fluorescence cuvette at 30 °C. Protoporphyrinogen, a nonfluorescent heme precursor (37Camadro J.-M. Chambon H. Jolles J. Labbe P. Eur. J. Biochem. 1986; 156: 579-587Crossref PubMed Scopus (64) Google Scholar), was added at 50 or 250 nm final concentration. Time traces were collected to monitor the appearance of PPIX (excitation 410 nm, emission 632 nm) and the appearance of zinc protoporphyrin (excitation 410 nm, emission 587 nm). Heme Synthesis in Permeabilized Cells (from Exogenous Iron)—Ferrous ammonium sulfate (10 μm) was prepared by dissolving in water and bubbling with argon in a septum-sealed vial. Iron was removed with a syringe and injected into the assay cuvette to give a final concentration of 10 μm. NADH (5 mm final concentration) was added at the same time as the iron and preincubated with the permeabilized cells for 2 min at 30 °C before each assay. Time traces (180 s) at 632 nm or repeated emission scans from 550 to 650 nm (each requiring 100 s) were collected. Protoporphyrinogen oxidase activity was measured fluorimetrically (38Camadro J.-M. Thome R. Brouillet N. Labbe P. J. Biol. Chem. 1994; 269: 32085-32091Abstract Full Text PDF PubMed Google Scholar) by treating the permeabilized cells with the iron and zinc chelator bipyridyl (10 mm added from a 1 m stock in ethanol) and dithiothreitol (5 mm) prior to the addition of the protoporphyrinogen. Heme Synthesis in Permeabilized Cells Measured by Radiolabeling with 55Fe—An aliquot of permeabilized cells (100 μl) was centrifuged in a microcentrifuge tube at 1500 × g at 4 °C for 10 min. Cells were resuspended in assay buffer (0.1 m Tris-Cl, 0.6 m sorbitol, pH 7.5), and the volume was adjusted to 83 μl. NADH (5 mm) and ferrous ascorbate (10 μm) were added, and the reaction was incubated at 30 °C for 2 min. Protoporphyrinogen (0.5 nmol) was added, and the reaction was incubated at 30 °C for an additional 3 min. The reaction was stopped by immersing the tube in ice water, and then 300 μl of HCl (0.2 m) was added. The tube was vortexed for 30 s. Methyl ethyl ketone (500 μl) was added, and the tube was vortexed for 30 s. The sample was centrifuged (20,000 × g) for 5 min, and 200 μl of the supernatant fraction was removed and subjected to scintillation counting. Other Procedures—Low temperature spectra (-191 °C) of cell extracts were obtained as described previously (39Labbe P. Chaix P. Bull. Soc. Chim. Biol. (Paris). 1969; 51: 1642-1644PubMed Google Scholar), with an optical path length of 1 mm with one sheet of wet filter paper in the reference path. Total heme content of the cells was determined by the pyridine hemochromogen method (40Porra R.J. Jones O.T. Biochemistry. 1963; 87: 181-185Google Scholar). Cell fractionation was performed by subjecting the permeabilized cells to Dounce homogenization and differential centrifugation in order to obtain mitochondrial fractions as described (41Murakami H. Pain D. Blobel G. J. Cell Biol. 1988; 107: 2051-2057Crossref PubMed Scopus (279) Google Scholar). Whole cell or mitochondrial lysates were obtained by exposing the permeabilized cells or mitochondria to lysis buffer containing 0.1 m Tris-Cl, pH 7.5, 0.5% Tween 80, followed by gentle bath sonication. Protein concentrations were measured using a BCA protein assay kit (Pierce). Synthetic Slow Growth Phenotype from Combining Δmrs3, Δmrs4, and Δyfh1—The pleiotropic Δyfh1 phenotype, characterized by accumulations of toxic iron in mitochondria and deficiencies of iron proteins, has been difficult to tease apart in terms of cause and effect. Deletions of MRS3 and MRS4 in the Δyfh1 context (ΔΔΔ) have been reported to revert the mitochondrial iron accumulation phenotype (23Foury F. Roganti T. J. Biol. Chem. 2002; 277: 24475-24483Abstract Full Text Full Text PDF PubMed Scopus (145) Google Scholar). Thus, in this mutant strain, deficiencies resulting from toxic mitochondrial iron overload should be ameliorated, whereas, by contrast, phenotypes resulting from interruption of iron trafficking or iron utilization should be exacerbated. A haploid parental strain was transformed with constructs to delete MRS4 and then to delete MRS3. The single and double mutants grew normally in the rich or defined medium used for selection of the knock-out transformants, and secondary genetic changes were not observed. By contrast, the Δyfh1 strain was slow growing and genetically unstable in air. More rapidly growing suppressor mutations appeared with high frequency, and in many of the suppressor mutants, a severe global heme deficiency, associated with the Δyfh1 mutation, was reverted (4Lesuisse E. Santos R. Matzanke B.F. Knight S.A. Camadro J.M. Dancis A. Hum. Mol. Genet. 2003; 12: 879-889Crossref PubMed Scopus (219) Google Scholar). In a previous report describing the triple mutant (Δmrs3/4/Δyfh1; ΔΔΔ), a Δyfh1 strain with normal cytochromes was used as the starting point, and therefore phenotypes of this strain or its derivatives due to heme deficiency may have been obscured by the presence of suppressor mutations (23Foury F. Roganti T. J. Biol. Chem. 2002; 277: 24475-24483Abstract Full Text Full Text PDF PubMed Scopus (145) Google Scholar). To minimize such problems from suppressors, shuffle strains were created in which the Δyfh1 deletion was "covered" by a plasmid carrying a wild-type YFH1 genomic allele. Three crosses were performed between the parental strain and the Δyfh1 shuffle, the Δmrs3/4 mutant, or the ΔΔΔ shuffle strain, respectively. The covering YFH1 plasmids were removed from the diploid shuffle strains by counterselection with cycloheximide, exposing the Δyfh1 allele. The diploids, which appeared uniform in their growth properties, were then sporulated, and tetrads were dissected. Tetrad clones were photographed after 5 days, and genotypes were determined by PCR with appropriate primers. The backcross of Δyfh1 yielded two larger wild-type and two smaller Δyfh1 tetrad colonies (Fig. 1A). The backcross of the Δmrs3/4 strain yielded tetrads of all expected genotypic combinations (MRS3 and MRS4 are unlinked), and colony sizes were indistinguishable from wild-type in all cases (Fig. 1B). In the cross involving Δmrs3/4 and Δyfh1, tiny colonies were observed (Fig. 1C). In all cases, these were confirmed to carry three mutations: Δmrs3, Δmrs4, and Δyfh1. Congenic strains were grown in 96-well plates containing rich YPAD medium, and growth was followed by frequent turbidity measurements using a plate reader. Wild type was indistinguishable from Δmrs3/4 (short lag phase and 2-h doubling time in logarithmic phase). The Δyfh1 strain grew more slowly (much longer lag time and 5-h doubling time in logarithmic phase). The ΔΔΔ strain was the most severely impaired (longest lag phase and 8-h doubling time in logarithmic phase) (Fig. 2A). The small colony size of the triple mutant tetrad clone was thus not due to delayed germination but rather to genuine slow growth. In the final hours of the experiment (hours 30–40), growth of the triple mutant appeared to accelerate (Fig. 2A), perhaps due to outgrowth of suppressor mutant clones. These suppressors of the ΔΔΔ slow growth were also apparent as larger colonies surrounded by pinpoints in serial dilutions of the triple mutant grown on solid agar plates (Fig. 2B, ΔΔΔ). Effects of Oxygen Exposure, Heme, and Iron Availability on the Mutant Growth Phenotypes—A variety of growth conditions were tested to further characterize the cause of the severe slow growth of the ΔΔΔ mutant. Interestingly, all strains, including the triple mutant, grew at similar rates and formed similar sized colonies when grown anaerobically in rich YPAD medium with Tween 80 and ergosterol (Fig. 3A). The explanation for this observation is unknown at this time, but it could be due to less iron toxicity, different iron requirements of anaerobically grown cells, or activation of alternative and functionally redundant iron utilization systems under anaerobiosis. In any case, this surprising observation was useful, because it enabled us to initiate experiments with healthy, uniformly grown cells of different genotypes. Wild-type, Δmrs3/4, Δyfh1, and ΔΔΔ strains were grown anaerobically for 48 h in liquid medium allowing uniform growth, and serial dilutions were then inoculated on rich medium agar anaerobically (Fig. 3A) or defined medium agar plates in air (Fig. 3, B–F). After 3 days, photographs were taken. After switching to aerobic conditions, the wild type grew best, followed by Δmrs3/4, Δyfh1, and ΔΔΔ, respectively. The red color of the wild-type strain is due to accumulation of adenine precursor, which occurs as a consequence of the ade2–101 mutation. The decreased pigmentation apparent in the Δyfh1 and ΔΔΔ spots may be due to slower growth and/or decreased respiratory activity in these strains (42Jones E.W. Fink G.R. Strathern J.N. Jones E.W. Broach J.R. The Molecular Biology of the Yeast Saccharomyces Cerevisiae, Metabolism and Gene Expression. Cold Spring Harbor Laboratory, Cold Spring Harbo